Death and Seeking Alternative Therapy Largely Accounted for Lost to Follow-up of Patients on ART in Northwest Ethiopia: A Community Tracking Survey

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Wubshet, Mamo ^a,b   Berhane, Yemane ^b   Worku, Alemayehu ^b,c   Kebede, Yigzaw ^a  

^a UNIVERSITY OF GONDAR   (Ethiopia)

^b ADDIS CONTINENTAL INSTITUTE OF PUBLIC HEALTH   (Ethiopia)

^c ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AFRICA; ARTICLE; CASE MANAGER; COMMUNITY TRACKING SURVEY; DEATH; ETHIOPIA; FEMALE; FOLLOW UP; HEALTH CARE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COUNSELING; RISK FACTOR; TREATMENT OUTCOME;

ANTI-RETROVIRAL AGENTS; COMPLEMENTARY THERAPIES; DEATH; ETHIOPIA; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; KAPLAN-MEIER ESTIMATE; LOST TO FOLLOW-UP; MEDICATION ADHERENCE; PROPORTIONAL HAZARDS MODELS;

EID: 84875079747     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059197     Document Type: Article

References (30)

1. Assefa Y, Kiflie A, Tesfaye D, Mariam DH, Kloos H, et al. (2011) Outcomes of antiretroviral treatment program in Ethiopia: retention of patients in care is a major challenge and varies across health facilities. BMC Health Serv Res 11: 81.
2. Cornell M, Grimsrud A, Fairall L, Fox MP, van Cutsem G, et al. (2010) Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS 24: 2263-2270.
3. Egger M, Spycher BD, Sidle J, Weigel R, Geng EH, et al. (2011) Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa. PLoS Med 8: e1000390.
4. Rosen S, Fox MP, Gill CJ, (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 4: e298.
5. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, et al. (2008) Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ 86: 559-567.
6. Fox MP, Rosen S, (2010) Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health 15Suppl 1: 1-15.
7. Brinkhof MW, Pujades-Rodriguez M, Egger M, (2009) Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One 4: e5790.
8. Wubshet M, Berhane Y, Worku A, Kebede Y, Diro E (2012) High Loss to Followup and Early Mortality Create Substantial Reduction in Patient Retention at Antiretroviral Treatment Program in North-West Ethiopia. ISRN AIDS 2012.
9. Central Statistical Agency AA, Ethiopia (2011) Ethiopia Dmographic and Health Survey 2011. Addis Ababa, Ethiopia.
10. FMOH (2007). Implementation Guideline for TB/HIV Collaborative Activities in Ethiopia. Addis Ababa, Ethiopia.
11. FMOHE (2007) Antiretroviral treatment program implementation guideline in Ethiopia. In:. editor. Addis Ababa (Ethiopia) Ministry of Health.
12. WHO/UNAIDS (2006) Patient monitoring guidelines for HIV care and Antiretroviral Therapy(ART). Geneva, Switzerland WHO press.
13. Abeysekera WWM, Sooriyarachchi M.R. (2009) Use of Schoenfeld's global test to test the proportional hazards assumption in the Cox proportional hazards model: an application to a clinical study. JNatnSciFoundation Sri Lanka: 41-51.
14. Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, et al. (2010) Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr 53: 405-411.
15. Yu JK, Chen SC, Wang KY, Chang CS, Makombe SD, et al. (2007) True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bull World Health Organ 85: 550-554.
16. Deribe K, Hailekiros F, Biadgilign S, Amberbir A, Beyene BK, (2008) Defaulters from antiretroviral treatment in Jimma University Specialized Hospital, Southwest Ethiopia. Trop Med Int Health 13: 328-333.
17. Zwahlen M, Harris R, May M, Hogg R, Costagliola D, et al. (2009) Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. Int J Epidemiol 38: 1624-1633.
18. Yiannoutsos CT, An MW, Frangakis CE, Musick BS, Braitstein P, et al. (2008) Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS One 3: e3843.
19. Geng EH, Emenyonu N, Bwana MB, Glidden DV, Martin JN, (2008) Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA 300: 506-507.
20. Brinkhof MW, Spycher BD, Yiannoutsos C, Weigel R, Wood R,et al. Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa. PLoS One 5: e14149.
21. Lawn SD, Myer L, Harling G, Orrell C, Bekker LG, et al. (2006) Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis 43: 770-776.
22. Hsiao AF, Wong MD, Kanouse DE, Collins RL, Liu H, et al. (2003) Complementary and alternative medicine use and substitution for conventional therapy by HIV-infected patients. J Acquir Immune Defic Syndr 33: 157-165.
23. Namuddu B, Kalyango JN, Karamagi C, Mudiope P, Sumba S, et al. (2011) Prevalence and factors associated with traditional herbal medicine use among patients on highly active antiretroviral therapy in Uganda. BMC Public Health 11: 855.
24. I-TECH (2011) Patients lost to follow-up: research into the tradition of holy water and implications for patient adherence to antiretroviral therapy in Ethiopia.: University of Washington.
25. Forster M, Bailey C, Brinkhof MW, Graber C, Boulle A, et al. (2008) Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings. Bull World Health Organ 86: 939-947.
26. Mulissa Z, Jerene D, Lindtjorn B, (2010) Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia. PLoS One 5: e13268.
27. Nansera D, Bajunirwe F, Elyanu P, Asiimwe C, Amanyire G, et al. (2012) Mortality and loss to follow-up among tuberculosis and HIV co-infected patients in rural southwestern Uganda. Int J Tuberc Lung Dis.
28. Hermans SM, Kiragga AN, Schaefer P, Kambugu A, Hoepelman AI, et al. (2010) Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa. PLoS One 5: e10527.
29. Conley NJ, Pavlinac PB, Guthrie BL, Mackelprang RD, Muiru AN, et al. (2012) Distance from Home to Study Clinic and Risk of Follow-Up Interruption in a Cohort of HIV-1-Discordant Couples in Nairobi, Kenya. PLoS One 7: e43138.
30. Weigel R, Hochgesang M, Brinkhof MW, Hosseinipour MC, Boxshall M, et al. (2011) Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi. BMC Infect Dis 11: 31.